Conversely, an analysis of 1488 DCIS patients found that higher TILs were linked to HER2+ phenotype, higher grade, and necrosis, but had no effect on ipsilateral DCIS or invasive tumor recurrence, regardless of treatment approach (51). This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.